Miia Kivipelto
#73,099
Most Influential Person Now
Finnish neurologist
Miia Kivipelto's AcademicInfluence.com Rankings
Miia Kivipeltomedical Degrees
Medical
#804
World Rank
#1054
Historical Rank
Neurology
#164
World Rank
#233
Historical Rank
Download Badge
Medical
Miia Kivipelto's Degrees
- Doctorate Medicine University of Helsinki
Why Is Miia Kivipelto Influential?
(Suggest an Edit or Addition)According to Wikipedia, Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease. Early life and education Kivipelto was born in Alajärvi, Finland in 1973. She studied medicine at the University of Kuopio and received her MD in 1999, specializing in geriatrics. She received her PhD in 2002 after defending her dissertation on vascular risk factors in Alzheimer's disease. In a 2017 interview, Kivipelto attributed her interest in dementia, Alzheimer's, and diseases of aging to her close relationship with her grandmother, who developed Alzheimer's when she was young.
Miia Kivipelto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2015) (4436)
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment (2004) (4172)
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial (2015) (2030)
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
- Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study (2001) (1565)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1475)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
- Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. (2005) (1198)
- Defeating Alzheimer's disease and other dementias: a priority for European science and society (2016) (1172)
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria (2016) (1163)
- Alzheimer's disease: clinical trials and drug development (2010) (1066)
- Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease (2005) (1018)
- Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention (2009) (899)
- Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy (2010) (848)
- Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study (2006) (792)
- Midlife vascular risk factors and late-life mild cognitive impairment (2001) (736)
- Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
- Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (579)
- Hippocampus and entorhinal cortex in mild cognitive impairment and early AD (2004) (573)
- Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
- Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease (2002) (548)
- Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 (2014) (538)
- Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease (2018) (534)
- Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later (2009) (486)
- Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 (2017) (452)
- Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
- The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress (2013) (385)
- Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis (2010) (371)
- Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. (2009) (363)
- Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies (2015) (360)
- Diabetes, Alzheimer disease, and vascular dementia (2010) (330)
- BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study (2008) (315)
- Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study (2004) (311)
- Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects (2004) (297)
- Serum cholesterol changes after midlife and late-life cognition (2007) (291)
- Advances in the prevention of Alzheimer's disease and dementia (2014) (290)
- Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. (2011) (290)
- Fat intake at midlife and cognitive impairment later in life: a population‐based CAIDE study (2008) (270)
- Association between mid-life marital status and cognitive function in later life: population based cohort study (2009) (261)
- Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study (2006) (260)
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease (2010) (248)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing (2020) (243)
- Metabolome in progression to Alzheimer's disease (2011) (238)
- Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study (2008) (228)
- A voxel based morphometry study on mild cognitive impairment (2004) (224)
- Diffusion tensor imaging and Tract-Based Spatial Statistics in Alzheimer's disease and mild cognitive impairment (2011) (215)
- Education and dementia (2007) (214)
- Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals (2018) (213)
- Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial (2017) (204)
- Caffeine as a protective factor in dementia and Alzheimer's disease. (2010) (203)
- Future directions in Alzheimer's disease from risk factors to prevention. (2014) (201)
- Total cholesterol and the risk of Parkinson disease (2008) (197)
- The effect of midlife physical activity on structural brain changes in the elderly (2010) (196)
- Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. (2013) (192)
- World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia (2019) (183)
- Midlife risk score for the prediction of dementia four decades later (2014) (183)
- Body mass index and the risk of Parkinson disease (2006) (179)
- Dementia prevention: current epidemiological evidence and future perspective (2012) (176)
- Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia (2015) (172)
- Diabetes, Alzheimer disease, and vascular dementia A population-based neuropathologic study (2013) (167)
- Clinical trials in mild cognitive impairment: lessons for the future (2005) (167)
- Why has therapy development for dementia failed in the last two decades? (2016) (165)
- Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women (2006) (158)
- Introduction: Mild cognitive impairment: beyond controversies, towards a consensus (2004) (155)
- Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence (2006) (149)
- 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial (2017) (148)
- High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. (2010) (148)
- Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study. (2014) (146)
- MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study (2008) (146)
- Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment (2007) (141)
- Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies. (2014) (140)
- Tocopherols and tocotrienols plasma levels are associated with cognitive impairment (2012) (140)
- Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics. (2012) (139)
- Stroke: Working Toward a Prioritized World Agenda (2010) (136)
- Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. (2012) (135)
- Acetylcholinesterase and Its Inhibition in Alzheimer Disease (2004) (131)
- Serum total cholesterol, statins and cognition in non-demented elderly (2009) (128)
- Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care (2020) (127)
- Homocysteine and holotranscobalamin and the risk of Alzheimer disease (2010) (121)
- Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. (2013) (119)
- Association of Blood Pressure and Hypertension With the Risk of Parkinson Disease: The National FINRISK Study (2011) (117)
- Risk and protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: variation by age and sex (2004) (115)
- Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial (2018) (114)
- Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer’s Disease, and Dementia: From FINGER to World-Wide FINGERS (2019) (114)
- BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function. (2016) (113)
- A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. (2008) (106)
- Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers (2014) (104)
- Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis (2016) (103)
- Serum high sensitivity C-reactive protein and cognitive function in elderly women. (2007) (102)
- Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults (2013) (101)
- Methodological challenges in designing dementia prevention trials — The European Dementia Prevention Initiative (EDPI) (2012) (100)
- Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. (2012) (99)
- Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study (2012) (97)
- Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the future (2020) (97)
- Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish Brain Power initiative (2012) (95)
- Midlife income, occupation, APOE status, and dementia: A population-based study (2002) (90)
- Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. (2013) (87)
- Carotid Intima-Media Thickness and Cognitive Function in Elderly Women: A Population-Based Study (2007) (86)
- Work‐related physical activity and the risk of dementia and Alzheimer's disease (2007) (85)
- Alzheimer's disease (2021) (85)
- Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
- Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment (2016) (84)
- Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer’s Disease (2002) (83)
- Rethinking the Dementia Diagnoses in a Population-Based Study: What Is Alzheimer’s Disease and What Is Vascular Dementia? (2006) (82)
- Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease (2009) (81)
- The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based Cohort (2013) (81)
- A new metabolomic workflow for early detection of Alzheimer's disease. (2013) (81)
- Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? (2006) (79)
- HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. (2010) (78)
- Alcohol Drinking and Cognitive Functions: Findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) Study (2006) (76)
- The Stroke Riskometer™ App: Validation of a data collection tool and stroke risk predictor (2014) (76)
- Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study (2010) (75)
- New strategy to reduce the global burden of stroke. (2015) (75)
- Alzheimer’s disease — The ways of prevention (2008) (73)
- Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α‐/γ‐tocotrienols and γ‐tocopherol (2013) (72)
- Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults: A Longitudinal Population-Based Study. (2016) (72)
- Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes. (2014) (72)
- Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders (2007) (71)
- Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future (2015) (71)
- High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice (2005) (70)
- Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease. (2010) (69)
- Midlife Work-Related Stress Increases Dementia Risk in Later Life: The CAIDE 30-Year Study (2016) (68)
- Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial † (2014) (68)
- The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia (2015) (67)
- Dementia registries around the globe and their applications: A systematic review (2017) (66)
- Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study (2011) (66)
- Are the neuroprotective effects of exercise training systemically mediated? (2019) (65)
- Advances in the prevention of Alzheimer's Disease (2015) (64)
- Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial. (2019) (64)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- Sleep disturbances and dementia risk: A multicenter study (2018) (63)
- The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. (2014) (63)
- The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics ⁎ ⁎ Roy W. Jones and Miia Kivipelto contributed equally to the content of the manuscript. (2008) (62)
- Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment. (2010) (60)
- Dementia risk in renal dysfunction (2017) (59)
- Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2019) (59)
- Incidence of stroke in people with Alzheimer disease (2013) (59)
- 36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease (2020) (58)
- European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol (2018) (57)
- Usefulness of repeated presentation of Mini‐Mental State Examination as a diagnostic procedure – a population‐based study (2002) (57)
- Cortical Thickness Analysis to Detect Progressive Mild Cognitive Impairment: A Reference to Alzheimer’s Disease (2009) (57)
- FACTORS ASSOCIATED WITH RESISTANCE TO DEMENTIA DESPITE HIGH ALZHEIMER DISEASE PATHOLOGY (2009) (57)
- Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials (2019) (55)
- Dietary changes and cognition over 2 years within a multidomain intervention trial—The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2018) (54)
- Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study. (2010) (54)
- Midlife Healthy-Diet Index and Late-Life Dementia and Alzheimer's Disease (2011) (54)
- Postmenopausal hormone therapy and Alzheimer disease (2017) (53)
- Cholinesterase inhibition: is there evidence for disease-modifying effects? (2009) (53)
- Homocysteine and holo‐transcobalamin and the risk of dementia and Alzheimers disease: a prospective study (2009) (53)
- Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. (2012) (53)
- Exercise, fitness and cognition – A randomised controlled trial in older individuals: The DR's EXTRA study (2010) (53)
- Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor-Based Morphometry and Voxel-Based Morphometry (2012) (53)
- Structural brain changes and cognition in relation to markers of vascular dysfunction (2012) (50)
- History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study (2013) (50)
- New Insights into Alzheimer's Disease Progression: A Combined TMS and Structural MRI Study (2011) (49)
- The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial. (2017) (48)
- Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis (2022) (48)
- Stroke: Working toward a Prioritized World Agenda (2010) (45)
- Cortical thickness in frontotemporal dementia, mild cognitive impairment, and Alzheimer's disease. (2012) (44)
- Serum lipids and hippocampal volume: The link to Alzheimer's disease? (2004) (44)
- World Wide Fingers will advance dementia prevention (2018) (44)
- Whole brain atrophy rate predicts progression from MCI to Alzheimer’s disease (2010) (43)
- Onset and Rate of Cognitive Change Before Dementia Diagnosis: Findings From Two Swedish Population-Based Longitudinal Studies (2010) (43)
- Stroke: Working toward a Prioritized World Agenda (2010) (42)
- Dementia after age 75: survival in different severity stages and years of life lost. (2012) (41)
- Cholesterol-modifying strategies for Alzheimer’s disease (2009) (41)
- How can dementia and disability be prevented in older adults: where are we today and where are we going? (2020) (40)
- Changes in Lifestyle, Behaviors, and Risk Factors for Cognitive Impairment in Older Persons During the First Wave of the Coronavirus Disease 2019 Pandemic in Finland: Results From the FINGER Study (2021) (39)
- Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study. (2017) (39)
- GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients. (2012) (39)
- Computer-based cognitive training for older adults: Determinants of adherence (2019) (38)
- Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment. (2015) (36)
- Development and Validation of an Interactive Internet Platform for Older People: The Healthy Ageing Through Internet Counselling in the Elderly Study. (2017) (36)
- Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition (2017) (36)
- Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. (2013) (36)
- The Nordic diet and cognition – The DR's EXTRA Study (2015) (34)
- Association of long-term dietary fat intake, exercise, and weight with later cognitive function in the Finnish Diabetes Prevention Study (2016) (34)
- Association between mid‐ to late life physical fitness and dementia: evidence from the CAIDE study (2014) (34)
- Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging. (2015) (34)
- Cardiorespiratory Fitness and Cognition: Longitudinal Associations in the FINGER Study. (2019) (33)
- Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies (2020) (33)
- Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older. (2004) (33)
- Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study (2008) (33)
- Risk factors for incident dementia in the very old (2013) (32)
- Prevention of Alzheimer's disease: moving backward through the lifespan. (2012) (32)
- The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0 (2019) (31)
- Sleep disturbances and the speed of multimorbidity development in old age: results from a longitudinal population-based study (2020) (31)
- CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia (2016) (30)
- Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study (2019) (30)
- Association of Methionine to Homocysteine Status With Brain Magnetic Resonance Imaging Measures and Risk of Dementia. (2019) (30)
- Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial. (2018) (29)
- Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study (2015) (29)
- Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial. (2017) (28)
- Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting. (2011) (28)
- Development of a Late-Life Dementia Prediction Index with Supervised Machine Learning in the Population-Based CAIDE Study (2016) (28)
- Changes in vascular factors 28 years from midlife and late-life cortical thickness (2013) (28)
- Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study (2018) (28)
- AMYPAD Diagnostic and Patient Management Study: Rationale and design (2018) (27)
- Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
- Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial (2017) (26)
- Cardiovascular health metrics from mid- to late-life and risk of dementia: A population-based cohort study in Finland (2020) (26)
- The Effect of Multidomain Lifestyle Intervention on Daily Functioning in Older People (2019) (26)
- Serum Testosterone Levels in Males with Alzheimer's Disease (2004) (26)
- Apolipoprotein E, B vitamins, and cognitive function in older adults. (2005) (25)
- Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial (2020) (24)
- Reduction of PINK1 or DJ‐1 impair mitochondrial motility in neurites and alter ER‐mitochondria contacts (2018) (24)
- Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial (2020) (24)
- Preventing Alzheimer Disease and Cognitive Decline (2011) (24)
- Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 (2021) (23)
- Can lifestyle changes prevent cognitive impairment? (2017) (23)
- Older Adults' Reasons for Participating in an eHealth Prevention Trial: A Cross-Country, Mixed-Methods Comparison. (2019) (23)
- Sleep disturbances and later cognitive status: a multi-centre study. (2018) (23)
- Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2010) (23)
- Health-related quality of life in a multidomain intervention trial to prevent cognitive decline (FINGER) (2017) (23)
- A Prospective Study on the Development of Alzheimer’s Disease with Regard to Thyroid-Stimulating Hormone and Homocysteine (2009) (23)
- Midlife work-related stress is associated with late-life cognition (2017) (23)
- Long‐term dementia risk prediction by the LIBRA score: A 30‐year follow‐up of the CAIDE study (2019) (22)
- Promoting safe walking among older people: the effects of a physical and cognitive training intervention vs. physical training alone on mobility and falls among older community-dwelling men and women (the PASSWORD study): design and methods of a randomized controlled trial (2018) (22)
- Alzheimer disease: To what extent can Alzheimer disease be prevented? (2014) (22)
- Differential Hypometabolism Patterns according to Mild Cognitive Impairment Subtypes (2008) (22)
- Late-life cynical distrust, risk of incident dementia, and mortality in a population-based cohort (2014) (22)
- Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities (2021) (21)
- Healthy Dietary Changes in Midlife Are Associated with Reduced Dementia Risk Later in Life (2018) (21)
- Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions (2021) (21)
- Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults (2018) (21)
- European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials (2018) (21)
- Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK) (2010) (21)
- Oophorectomy, hysterectomy, and risk of Alzheimer's disease: a nationwide case-control study. (2014) (20)
- APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. (2001) (20)
- Diabetes, glycaemia, and cognition—a secondary analysis of the Finnish Diabetes Prevention Study (2016) (20)
- Acute kidney injury and mortality risk in older adults with COVID-19 (2021) (20)
- Bisphosphonates and mortality: confounding in observational studies? (2019) (20)
- The Effect of Apolipoprotein Polymorphism on Brain in Mild Cognitive Impairment: A Voxel-Based Morphometric Study (2006) (19)
- Prevalence of dementia and factors associated with dementia in rural Bangladesh: data from a cross-sectional, population-based study (2014) (19)
- Preventive neurology (2009) (18)
- Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study (2020) (18)
- Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers (2018) (18)
- Decreased brain creatine levels in elderly apolipoprotein E ε4 carriers (2003) (18)
- Sex differences in dementia and response to a lifestyle intervention: Evidence from Nordic population‐based studies and a prevention trial (2021) (18)
- Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms (2012) (18)
- Health status and risk profiles for brain aging of rural‐dwelling older adults: Data from the interdisciplinary baseline assessments in MIND‐China (2022) (17)
- Cognition in the Finnish diabetes prevention study. (2015) (16)
- Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19 (2021) (16)
- A MULTIDOMAIN, TWO-YEAR, RANDOMIZED CONTROLLED TRIAL TO PREVENT COGNITIVE IMPAIRMENT: THE FINGER STUDY (2014) (16)
- Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. (2019) (16)
- The MOPEAD project: Advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community (2019) (15)
- Coronary Heart Disease and Cortical Thickness, Gray Matter and White Matter Lesion Volumes on MRI (2014) (15)
- Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses (2012) (14)
- Prevention Matters: Time for Global Action and Effective Implementation. (2018) (14)
- Dementia risk scores as surrogate outcomes for lifestyle‐based multidomain prevention trials—rationale, preliminary evidence and challenges (2020) (14)
- Statin therapy in Alzheimer's disease (2005) (14)
- Prevention of cognitive decline in old age-varying effects of interventions in different populations. (2019) (14)
- Ketosis After Intake of Coconut Oil and Caprylic Acid—With and Without Glucose: A Cross-Over Study in Healthy Older Adults (2020) (14)
- CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population‐based autopsy study (2018) (14)
- Effects of physical and cognitive training on gait speed and cognition in older adults: A randomized controlled trial (2021) (14)
- Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid (2019) (14)
- Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study. (2019) (13)
- Elevated systolic blood pressure and high cholesterol levels at midlife are risk factors for late-life dementia (2000) (13)
- Cardiorespiratory fitness and brain volumes in men and women in the FINGER study (2017) (13)
- A population-based neuropathologic study (2010) (12)
- Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations (2022) (12)
- Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design (2021) (12)
- Decreased brain creatine levels in elderly apolipoprotein E epsilon 4 carriers. (2003) (12)
- Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort Study. (2017) (11)
- Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline (2018) (11)
- Self‐rated physical fitness and estimated maximal oxygen uptake in relation to all‐cause and cause‐specific mortality (2018) (11)
- Attitudes of at-risk older adults about prevention of cardiovascular disease and dementia using eHealth: a qualitative study in a European context (2020) (11)
- Exercise, diet, and cognition in a 4-year randomized controlled trial: Dose-Responses to Exercise Training (DR's EXTRA) (2021) (11)
- Machine Learning and Social Robotics for Detecting Early Signs of Dementia (2017) (11)
- Hypertension and white matter lesions of the brain. (2002) (10)
- Multimodal Capture of Patient Behaviour for Improved Detection of Early Dementia: Clinical Feasibility and Preliminary Results (2021) (10)
- COVID-19 pandemic and mortality in nursing homes across USA and Europe up to October 2021 (2022) (10)
- The effect of adherence on cognition in a multidomain lifestyle intervention (FINGER) (2021) (10)
- Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia (2020) (10)
- Muscle strength and cognition in ageing men and women: The DR's EXTRA study (2017) (10)
- A clinical trial investigating the effects of fortasyn connect (souvenaid) in prodromal Alzheimer’s disease: results of the LipiDiDiet study (2016) (10)
- A Rare Success against Alzheimer's. (2017) (10)
- Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index (2021) (10)
- Impact of the COVID‐19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World‐Wide FINGERS (2021) (10)
- Can exercise training teach us how to treat Alzheimer’s disease? (2022) (10)
- Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk (2018) (10)
- Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk (2021) (9)
- Prevention of Alzheimer’s Disease: Intervention Studies (2013) (9)
- Dementia Research Fit for the Planet: Reflections on Population Studies of Dementia for Researchers and Policy Makers Alike (2020) (9)
- Red Cell Distribution Width and Dementia Among Rural-Dwelling Older Adults: The MIND-China Study (2021) (9)
- Vascular risk factors, ApoE ϵ4 allele, and gender and the risk of Alzheimer's disease: perspectives on prevention (2002) (9)
- Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis (2020) (9)
- Capillary blood tests may overestimate ketosis: Triangulation between three different measures of beta-hydroxybutyrate. (2019) (8)
- 27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial (2021) (8)
- Midlife income, occupation, APOE status, and dementia (2002) (8)
- Everyday Life Meaningfulness for the Community-Dwelling Oldest Old During the COVID-19 Pandemic (2021) (8)
- Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study (2021) (8)
- From Heart Health to Brain Health: Legacy of the North Karelia Project for Dementia Research. (2016) (8)
- Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial (2018) (8)
- Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention (2021) (8)
- Influence of Cognitive Reserve on Cognitive Trajectories (2021) (8)
- Leisure-Time and Occupational Physical Activity in Early and Late Adulthood in Relation to Later Life Physical Functioning. (2016) (8)
- Integrating nurses’ experiences with supporting behaviour change for cardiovascular prevention into a self-management internet platform in Finland and the Netherlands: a qualitative study (2019) (8)
- Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future Directions (2021) (8)
- Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline (2020) (7)
- Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: the CAIDE85+ study protocol (2020) (7)
- Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease (2019) (7)
- Dementia research priorities—2 (2017) (7)
- White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial (2020) (7)
- Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial (2020) (7)
- Serum proBDNF Is Associated With Changes in the Ketone Body β-Hydroxybutyrate and Shows Superior Repeatability Over Mature BDNF: Secondary Outcomes From a Cross-Over Trial in Healthy Older Adults (2021) (7)
- Factors Predicting Engagement of Older Adults With a Coach-Supported eHealth Intervention Promoting Lifestyle Change and Associations Between Engagement and Changes in Cardiovascular and Dementia Risk: Secondary Analysis of an 18-Month Multinational Randomized Controlled Trial (2021) (7)
- Dementia prevention: The potential long‐term cost‐effectiveness of the FINGER prevention program (2022) (7)
- Lifestyle intervention to prevent cognitive impairment (2016) (6)
- The new cholesterol controversy – a little bit of history repeating? (2006) (6)
- Use of new technology to improve dementia prevention: The Healthy Aging Through Internet Counseling in the Elderly (HATICE) project (2013) (6)
- [Almost two-thirds of the elderly with covid-19 surviving in nursing homes]. (2020) (6)
- The LipiDiDiet study: Rationale and study design (2012) (6)
- Combining Cognitive Markers to Identify Individuals at Increased Dementia Risk: Influence of Modifying Factors and Time to Diagnosis (2020) (6)
- cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders (2020) (6)
- Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive decline (2021) (6)
- EFFECTS OF A MULTIDOMAIN LIFESTYLE INTERVENTION ON OVERALL RISK FOR DEMENTIA: THE FINGER RANDOMIZED CONTROLLED TRIAL (2018) (6)
- Influence of Cognitive Reserve on Cognitive Trajectories Role of Brain Pathologies (6)
- Practical lessons from amyloid immunotherapy trials in Alzheimer disease. (2012) (6)
- Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial (2022) (5)
- Trajectories of cognitive decline and dementia development: A 12‐year longitudinal study (2022) (5)
- Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial (2021) (5)
- Associations between Prospective and Retrospective Subjective Memory Complaints and Neuropsychological Performance in Older Adults: The Finger Study (2018) (5)
- Body mass index and the risk of Parkinson´s disease (2006) (5)
- Earlier life leisure-time physical activity in relation to age-related frailty syndrome. (2020) (5)
- Vascular Risk Factors and Risk for Alzheimer’s Disease and Mild Cognitive Impairment: Population-Based Studies (2008) (5)
- Multimodal Preventive Trial for Alzheimer’s Disease: MIND-ADmini Pilot Trial Study Design and Progress (2022) (5)
- Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines (2022) (5)
- The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors (2022) (5)
- Digital Screening for Cognitive Impairment — A Proof of Concept Study (2021) (5)
- U.S. POINTER: STUDY DESIGN AND LAUNCH (2019) (5)
- Cerebral embolism and Alzheimer's disease (2006) (4)
- A clinical trial investigating the effects of souvenaid in prodromal Alzheimer's disease: progress and baseline characteristics of the lipididiet study (2014) (4)
- MANAGEMENT OF VASCULAR AND LIFESTYLE-RELATED RISK FACTORS FOR ALZHEIMER'S DISEASE AND DEMENTIA IN OLDER ADULTS: A EUROPEAN PERSPECTIVE (2014) (4)
- Effect of multidomain interventions on estimated dementia and cardiovascular risk reduction: An individual‐participant data meta‐analysis from FINGER, MAPT, and pre‐DIVA (2020) (4)
- Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index (2020) (4)
- Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 (2021) (4)
- U.S. POINTER (USA) (2020) (4)
- ACCEPT–HATICE: A MIXED METHODS STUDY OF FACILITATORS AND BARRIERS TO PARTICIPATION IN AN INTERNET-BASED MULTIDOMAIN TRIAL FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND COGNITIVE DECLINE IN OLDER EUROPEAN ADULTS (2017) (4)
- Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy (2021) (4)
- Health, Lifestyle, and Psycho-Social Determinants of Poor Sleep Quality During the Early Phase of the COVID-19 Pandemic: A Focus on UK Older Adults Deemed Clinically Extremely Vulnerable (2021) (4)
- A randomized controlled trial investigating the effects of Souvenaid in prodromal Alzheimer's disease: Baseline characteristics of the LipiDiDiet study (2013) (4)
- Faculty Opinions recommendation of A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. (2015) (4)
- Improving data sharing in research with context-free encoded missing data (2017) (4)
- Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs. (2012) (3)
- O3.19: A multidomain two-year randomized controlled trial to prevent cognitive impairment – the FINGER study (2014) (3)
- MID-LIFE WORK-RELATED STRESS INCREASES DEMENTIA RISK IN LATE-LIFE: THE CAIDE 30-YEAR STUDY (2014) (3)
- FEASIBILITY OF DIETARY INTERVENTION AMONG INDIVIDUALS WITH ELEVATED RISK OF DEMENTIA: 1ST-YEAR RESULTS FROM THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2014) (3)
- Pointing the FINGER at multimodal dementia prevention – Authors' reply (2015) (3)
- Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD (2022) (3)
- Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change. (2019) (3)
- Experiences of Participation in a Multimodal Preventive Trial MIND-ADMINI Among Persons with Prodromal Alzheimer’s Disease: A Qualitative Study (2022) (3)
- EFFECTS OF FORTASYN CONNECT (SOUVENAID) ON LONGITUDINAL BRAIN ATROPHY MEASURES IN PRODROMAL ALZHEIMER’S DISEASE: RESULTS OF THE DOUBLE-BLIND RANDOMISED CONTROLLED LIPIDIDIET TRIAL (2016) (3)
- Personal Social Networks of Community-Dwelling Oldest Old During the Covid-19 Pandemic—A Qualitative Study (2021) (3)
- 9th Key symposium Introduction: Updating Alzheimer's disease diagnosis implications for prevention and treatment (2014) (3)
- Correction: Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study (2015) (3)
- ADHERENCE TO MULTIDOMAIN INTERVENTIONS FOR THE PREVENTION OF ALZHEIMER’S DISEASE: DATA FROM THE MAPT AND FINGER TRIALS (2017) (3)
- The Epidemiology and Prevention of Alzheimer’s Disease and Projected Burden of Disease (2014) (3)
- Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments (2022) (3)
- MULTIDOMAIN LIFESTYLE INTERVENTION BENEFITS A LARGE ELDERLY POPULATION AT RISK FOR COGNITIVE DECLINE: SUBGROUP ANALYSES OF THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2017) (3)
- INCREASING ADHERENCE IN A CENTER-BASED TRIAL OF LIFESTYLE INTERVENTION IN OLDER INDIVIDUALS: U.S. POINTER TRIAL (2018) (3)
- HEALTHY AGEING THROUGH INTERNET COUNSELLING IN THE ELDERLY (HATICE): AN ONGOING RANDOMISED CONTROLLED TRIAL (2017) (3)
- HEALTHY AGEING THROUGH INTERNET COUNSELLING IN THE ELDERLY (HATICE): AN ONGOING RANDOMISED CONTROLLED TRIAL (2016) (3)
- Good for the heart and good for the brain? (2019) (2)
- Using an electronic frailty index to predict adverse outcomes in geriatric COVID-19 patients: data from the Stockholm GeroCovid study (2021) (2)
- Midlife improvements in financial situation are associated with a reduced dementia risk later in life: the CAIDE 30-year study (2019) (2)
- Association Between Iron-Related Protein Lipocalin 2 and Cognitive Impairment in Cerebrospinal Fluid and Serum (2021) (2)
- Homocysteine, holotranscobalamin and risk of Alzheimer's disease: A longitudinal population-based study (2009) (2)
- Midlife Work-Related Stress is Associated with Late-Life Gray Matter Volume Atrophy (2017) (2)
- Late‐life personality traits, cognitive impairment, and mortality in a population‐based cohort (2020) (2)
- Time-Varying Death Risk After SARS-CoV-2-Infection in Swedish Long-Term Care Facilities (2022) (2)
- Evaluation of a Novel Psychological Intervention Tailored for Patients With Early Cognitive Impairment (PIPCI): Study Protocol of a Randomized Controlled Trial (2020) (2)
- Dementia research in 2020: moving forward despite the COVID-19 pandemic (2021) (2)
- Vascular Cognitive Impairment in Clinical Practice: Vascular factors in Alzheimer's disease: from diagnostic dichotomy to integrative etiology (2009) (2)
- Erratum (2021) (2)
- Development of an Electronic Frailty Index for Hospitalized Older Adults in Sweden (2022) (2)
- From prediction to dementia prevention (2018) (2)
- Metabolome-wide association study on ABCA7 indicates a role of ceramide metabolism in Alzheimer’s disease (2022) (2)
- Blood pressure, memory, and executive function changes in late-life (2012) (2)
- The International Network on Public Health and Aging (INOPA): Introducing a Life Course Perspective to the Public Health Agenda (2008) (2)
- Prevention of dementia using mobile phone applications (PRODEMOS): A randomized controlled trial in progress (2020) (2)
- Temporal trends in hospitalizations and 30-day mortality in older patients during the COVID pandemic from March 2020 to July 2021 (2021) (2)
- MULTIDOMAIN LIFESTYLE INTERVENTION BENEFITS A LARGE ELDERLY POPULATION AT RISK FOR COGNITIVE DECLINE: SUBGROUP ANALYSES OF THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2017) (2)
- Alzheimer's Disease: back to the future (2006) (2)
- Healthy Diet at Midlife and the Risk of Late-Life Dementia and Alzheimer's Disease: A Population-based CAIDE Study (2009) (2)
- Multi-domain intervention studies to prevent dementia and AD (2014) (2)
- Forecasts for numbers of people living with dementia to 2050 and estimates for impact of smoking cessation: A modelling study in four European countries (2020) (2)
- Diet and cognition: Baseline associations in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2013) (2)
- Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders (2021) (2)
- O-056: Health-related quality of life in a multidomain intervention trial to prevent cognitive decline (the FINGER Study) (2015) (2)
- Pooling individual participant data from randomized controlled trials: Exploring potential loss of information (2020) (2)
- Decreased plasma C-reactive protein levels in APOE epsilon 4 allele carriers (2018) (2)
- Education-Based Cutoffs for Cognitive Screening of Alzheimer’s Disease (2022) (2)
- U.S. POINTER: Lessons learned about delivery of a multi‐domain lifestyle intervention during the COVID‐19 pandemic (2021) (1)
- Statins and dementia prevention: A population-based study (FINRISK) (2009) (1)
- Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trial (2022) (1)
- A Rare Success against Alzheimer's (2018) (1)
- Healthy habits - healthy brain. (2017) (1)
- The effects of a physical and cognitive training intervention vs. physical training alone on older adults’ physical activity: A randomized controlled trial with extended follow-up during COVID-19 (2021) (1)
- World's most prolific researcher in Alzheimer's disease: Professor Bengt Winblad (2011) (1)
- AU‐ARROW (Australia) (2020) (1)
- P3-155 Midlife dietary fats and the risk of late-life dementia: a population-based study (2004) (1)
- [New diagnostic criteria for Alzheimer disease]. (2011) (1)
- Depressive signs in midlife: A risk factor for cognitive impairment in later life? (2010) (1)
- Can dementia risk be reduced by following the American Heart Association's Life's Simple 7? A systematic review and dose-response meta-analysis (2022) (1)
- Late-life cynical distrust, incident dementia and mortality (2013) (1)
- DIETARY INTERVENTION ADHERENCE AND COGNITIVE CHANGES AMONG INDIVIDUALS WITH ELEVATED RISK OF DEMENTIA: THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2017) (1)
- Adopting the FINGER multimodal intervention methodology to prevent cognitive decline in Southern Europe: The GOIZ ZAINDU pilot study (2021) (1)
- Faculty Opinions recommendation of Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. (2015) (1)
- Dementia prevention in memory clinics: recommendations from the European task force for brain health services (2023) (1)
- Glucose tolerance and cognitive function in men and women: DR'S extra study (ISRCTN45977199) (2009) (1)
- 27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial (2021) (1)
- Sex-dependent effects of CYP46A1 overexpression on cognitive function during aging (2021) (1)
- Long‐term dietary intervention adherence among individuals with elevated risk of dementia: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2020) (1)
- The WW‐FINGERS‐SARS‐CoV2 initiative: Impact of the COVID‐19 pandemic on brain health and prevention strategies (2021) (1)
- Disease progression of cognitive impairment in Alzheimer's disease: A model-based approach (2009) (1)
- Does suppressing one’s emotions increase the risk of all‐cause dementia among older adults? (2020) (1)
- O3-01-04 Association between serum HDL cholesterol and hippocampal volume. A link to Alzheimer's disease (2004) (1)
- The Patient with Cognitive Impairment (2018) (1)
- Markers of vitamin B12 status in relation to cerebrospinal fluid biomarkers and cognitive performance (2020) (1)
- EURO‐FINGERS/UK FINGERS (Europe) (2020) (1)
- A competing risk joint model for dealing with different types of missing data in an intervention trial in prodromal Alzheimer’s disease (2021) (1)
- O1-02-06 A midlife risk score for the prediction of dementia more than three decades later (2007) (1)
- Blood pressure, apoe genotype, and dementia: The swedish brain power project (2009) (1)
- RISK SCORE FOR PREDICTION OF DEMENTIA RISK IN 10 YEARS AMONG OLDER ADULTS: A NORDIC POPULATION-BASED STUDY WITH THREE COHORTS (2017) (1)
- Salivary cortisol, Alzheimer's disease biomarkers and cognition among memory clinic patients (2017) (1)
- Occupational complexity and cognition in the FINGER multidomain intervention trial (2022) (1)
- FROM THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY TO THE GLOBAL DEMENTIA PREVENTION INITIATIVE: APPLICABILITY OF MULTI-DOMAIN INTERVENTIONS (2017) (1)
- Department of Error (2017) (1)
- Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study (2022) (1)
- Development of an electronic frailty index for hospitalized geriatric patients in Sweden (2021) (1)
- PARKINSON DISEASE. Authors' reply (2009) (1)
- Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study (2022) (1)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (1)
- Results and experiences from Scandinavian multi-domain intervention trials (DRs EXTRA and FINGER) (2012) (1)
- Response to "Comment on 'Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program'". (2023) (1)
- Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes (2022) (1)
- P2-278 Body mass index, clustering of vascular risk factors and the risk of dementia: a longitudinal, population-based study (2004) (1)
- Impact of Covid‐19 pandemic on lifestyle in a middle‐aged and elderly population (2021) (1)
- Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline (2022) (1)
- Cardiovascular health metrics from mid‐ to late‐life and risk of dementia: A population‐based study (2020) (1)
- Effects of Physical and Cognitive Training on Falls and Concern About Falling in Older Adults: Results From a Randomized Controlled Trial (2021) (1)
- 205: Lipitor’s Effect in Alzheimer’s Dementia (LEADe) Study: Baseline Characteristics (2007) (1)
- Suitability of dementia risk scores as surrogate outcomes for lifestyle‐based multidomain prevention trials (2020) (0)
- A competing risk joint model for dealing with different types of missing data in an intervention trial in prodromal Alzheimer’s disease (2021) (0)
- Robot‐assisted detection of subclinical dementia: Progress report and preliminary findings (2020) (0)
- CARE CAMPUS. A EUROPEAN CONSORTIUM MODEL TO SUPPORT FORMAL AND INFORMAL CAREGIVING TRAINING (2018) (0)
- Risk factor versus risk marker: Serum total cholesterol, its changes after midlife and late-life cognitive impairment (2009) (0)
- Erratum (1992) (0)
- Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD (2022) (0)
- COGNITIVE RESERVE: IMPLICATIONS FOR PREVENTION OFALZHEIMER’S DISEASE (2014) (0)
- Correction to: Bisphosphonates and mortality: confounding in observational studies (2021) (0)
- P4-127: The effect of midlife physical activity on subsequent structural brain changes (2008) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- MO358ACUTE KIDNEY INJURY AND MORTALITY RISK IN OLDER ADULTS WITH AND WITHOUT COVID-19: DATA FROM GEROCOVID STUDY (2021) (0)
- Engagement with a preventive eHealth intervention in older adults (the HATICE trial): Predictive factors and associations with dementia and cardiovascular risk (2021) (0)
- STRONGER 60+ Adaption of the multimodal FINGER model to prevent cognitive decline in a Swedish primary care rehabilitation unit: An effectiveness‐implementation hybrid design (2020) (0)
- USE OF HEALTH CARE SERVICES AMONG OLDER ADULTS PARTICIPATING IN A MULTIDOMAIN LIFESTYLE INTERVENTION TO PREVENT COGNITIVE IMPAIRMENT (FINGER) (2018) (0)
- Erratum to: Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease (2019) (0)
- Combining Cortical Thickness Analysis and Clinical Measures to Predict Alzheimer's Disease (2010) (0)
- Longitudinal study of Alzheimer's disease biomarkers, allostatic load, and cognition among memory clinic patients (2023) (0)
- A competing risk joint model for dealing with different types of missing data in an intervention trial in prodromal Alzheimer’s disease (2021) (0)
- O4-05-08: The impact of midlife smoking on the development of dementia and Alzheimer's disease later in life: A population-based study (2008) (0)
- Validation of a midlife dementia risk score in a large diverse population (2011) (0)
- Can mild cognitive impairment predict Alzheimer’s disease? (2005) (0)
- Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial (2021) (0)
- Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial (2021) (0)
- Cardiovascular and dementia risk scores and their association with dementia‐related biomarkers in a memory clinic population (2021) (0)
- [New criteria for Alzheimer disease. Use of biological markers for earlier and more precise diagnosis]. (2011) (0)
- Subject Index Vol. 28, 2007 (2007) (0)
- Current status and quantitative results of the AMYPAD prognostic and natural history study (2021) (0)
- Re: Marital status and dementia (2017) (0)
- Medication and management techniques can improve an Alzheimer’s patient’s memory, thinking, behavior, and functioning, according to new practice guidelines from the American Academy of Neurology. The comprehensive guidelines recommend choline- sterase inhibitors as standard care for people who have (2004) (0)
- Education halves the risk of dementia due to apolipoprotein ε4 allele: A collaborative study from the Swedish brain power initiative (2010) (0)
- [Treatment of early stages of Alzheimer's disease: New guidelines are in the pipeline]. (2013) (0)
- Lifestyle and behavior changes during the COVID19 pandemic in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2021) (0)
- Podium Presentations: Wednesday, July 19, 2017 P1221 F4-08-03 WITHDRAWN F4-08-04 BIG PHARMA IN VCID: WHAT WILL IT TAKE? (2017) (0)
- P1-247 Late-life body mass index and dementia risk (2006) (0)
- CAIDE DEMENTIA RISK SCORE AND CEREBROSPINAL FLUID ALZHEIMER BIOMARKERS (2014) (0)
- Sex and gender differences in genetic and lifestyle risk and protective factors for dementia (2021) (0)
- VITAMIN B12 AND FOLATE IN RELATION TO THE RATE OF BRAIN ATROPHY IN SUBJECTS AT RISK OF DEMENTIA: A LONGITUDINAL POPULATION BASED STUDY (2014) (0)
- Feelings of hopelessness in midlife are associated with dementia risk in later life (2012) (0)
- SLEEP EARLIER IN LIFE AND LATE-LIFE DEMENTIA: MULTI-CENTER POPULATION DATA FROM SWEDEN AND FINLAND. (2017) (0)
- Pre‐screening models for patient engagement: The MOPEAD project (2020) (0)
- Detection of cognitive disorders using web-based cognitive test battery: Validation against traditional methods (2017) (0)
- Blood β-synuclein is related to amyloid PET positivity in memory clinic patients. (2023) (0)
- DETECTING COGNITIVE DISORDERS USING MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS (2017) (0)
- 27‐hydroxycholesterol promotes oligodendrocytic maturation: Implications for Alzheimer’s disease (2021) (0)
- Bengt cohort study basedcognitive function in later life : population Association between mid-life marital status and (2009) (0)
- P1-263 Midlife to late-life serum cholesterol changes and the risk of cognitive impairment: A population-based study (2006) (0)
- WORLD WIDE FINGERS: A GLOBAL COLLABORATION FOR FUTURE GENERATIONS (2019) (0)
- Cortisol, cognition and Alzheimer’s disease biomarkers among memory clinic patients (2022) (0)
- Lifestyle-related Factors in Stroke and Dementia (2008) (0)
- Evolution of gray matter atrophy on serial MRI scans predicting the progression from MCI to Alzheimer's (2010) (0)
- The WW‐FINGERS‐SARS‐CoV‐2 initiative: a multinational survey to assess the effects of the COVID‐19 Pandemic on Lifestyle and Psychosocial factors relevant to Brain Health (2022) (0)
- Contents Vol. 26, 2008 (2008) (0)
- SEX DIFFERENCES IN DEMENTIA: EVIDENCE FROM POPULATION-BASED STUDIES AND THE FINGER LIFESTYLE INTERVENTION (2019) (0)
- Variations in blood pressure over 30 years and risk of dementia: A population-based study (2012) (0)
- Changes in dementia risk factors over 40 years: Experiences from Finland (2013) (0)
- Brain amyloid load and cognitive trajectories in older individuals at risk for dementia (2021) (0)
- Development of a healthy lifestyle index within a multidomain intervention aimed at prevention of cognitive impairment and dementia, and its association with cognition: Results from the FINGER trial (2021) (0)
- Effect of berries and fruits on cognitive change during a 2‐year multi‐domain lifestyle intervention: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2020) (0)
- Mental stimulation and multimodal trials to build resilience against cognitive impairment and Alzheimer´s disease (2019) (0)
- PATTERNS AND RATES OF COGNITIVE DECLINE DURING THE PRECLINICAL PHASE OF DEMENTIA: 12-YEAR FOLLOW-UP OF A POPULATION-BASED SAMPLE (2019) (0)
- MIDLIFE CAIDE DEMENTIA RISK SCORE AND LATE-LIFE STRUCTURAL BRAIN CHANGES ON MRI (2014) (0)
- Risk and protective factors for dementia in people 85 and older (2013) (0)
- Serum homocysteine, holotranscobalamin, folate and cognition in the elderly: A longitudinal population-based study (2011) (0)
- SOCIAL-BEHAVIORAL INTERVENTIONS: METHODS AND OUTCOMES F2-01-01 WHY ALZHEIMER PATIENTS AND CAREGIVERS PARTICIPATE IN RANDOMIZED CLINICAL TRIALS (0)
- ASSOCIATIONS OF LEUCOCYTE TELOMERE LENGTH WITH BRAIN MRI AND PIB-PET MEASURES: THE FINGER STUDY (2017) (0)
- World-Wide FINGERS: An International Network of Linked Multidomain Trials (2021) (0)
- Memantine offers new possibilities for the treatment of VaD (2002) (0)
- MIDLIFE COFFEE DRINKING AND DEMENTIA-RELATED BRAIN CHANGES ON MRI UP TO 28 YEARS LATER (2017) (0)
- Subject Index Vol. 26, 2008 (2008) (0)
- Metabolome-wide association study on ABCA7 demonstrates a role for ceramide metabolism in impaired cognitive performance and Alzheimer's disease (2021) (0)
- Re: Brain reserve or better strategic behaviour? (2017) (0)
- STUDY RECRUITMENT AND BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL: THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2014) (0)
- Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid (2019) (0)
- Amyloid immunotherapy trials in Alzheimer's disease: Experiences from a memory clinic (2010) (0)
- Re: On mid-life marital status and cognitive function in later life: notes inspired by a journal club discussion (2017) (0)
- The impact of COVID‐19 restrictions after one year on modifiable risk factors related to brain health in older adults in The Netherlands (2022) (0)
- Pointing the FINGER at multimodal dementia prevention Reply (2015) (0)
- Dementia prevention: current epidemiological evidence and future perspective (2012) (0)
- Transitions: Experiences of younger persons recently diagnosed with Alzheimer-type dementia (2023) (0)
- Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions (2022) (0)
- U.S. GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (U.S.-FINGER) (2017) (0)
- β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population (2022) (0)
- O2-04-02 Lipitor’s effect in Alzheimer’s dementia (LEADe) study: Baseline characteristics (2007) (0)
- THE IMPACT OF ADHERENCE TO MULTIDOMAIN LIFESTYLE INTERVENTION ON COGNITION: THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2017) (0)
- 27‐hydroxycholesterol promotes oligodendrocyte maturation: Implications for hypercholesterolemia‐associated brain white matter changes (2021) (0)
- COMBINING STRUCTURAL MRI, COGNITIVE AND GENETIC MARKERS IN PREDICTING FUTURE DEMENTIA: SIX-YEAR FOLLOW-UP OF A POPULATION-BASED SAMPLE (2017) (0)
- SERUM INSULIN AND THE RISK OF DEMENTIA AND COGNITIVE DECLINE: A LONGITUDINAL POPULATION-BASED STUDY (2017) (0)
- From FINGER to MET‐FINGER: metformin and lifestyle intervention for multimodal precision prevention of dementia (2022) (0)
- Gastrointestinal Diseases, Genetic Risk, and Incident Dementia: A Prospective Cohort Study in 352,463 Middle-Aged Adults (2022) (0)
- P4-071: Midlife coffee and tea drinking and later dementia: A population-based Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study (2008) (0)
- [Not Available]. (2006) (0)
- Re: Marital status and the risk of dementia (2017) (0)
- Stress and Alzheimer’s disease: Linking salivary cortisol to biomarkers of neurodegeneration and cognitive decline in a memory clinic cohort (2021) (0)
- Prevention of Age-Related Cognitive Impairment, Alzheimer’s Disease, and Dementia (2020) (0)
- VITAMIN B12, FOLATE, AND SULFUR AMINO-ACIDS AS RISK FACTORS FOR DEMENTIA AND COGNITIVE DECLINE: A LONGITUDINAL POPULATION-BASED STUDY (2017) (0)
- DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS (2017) (0)
- S1-03-04 Cholesterol and risk for Alzheimer's disease (2004) (0)
- S.23.01 Risk factors for Alzheimer's disease (2010) (0)
- Self-rated Physical Fitness And Estimated Maximal Oxygen Uptake In Relation To All-cause And Cause-specific Mortality: 1995 Board #147 June 2, 3: 30 PM - 5: 00 PM. (2016) (0)
- Transitions in early‐onset dementia: A qualitative study exploring the experiences of people recently diagnosed with dementia (2020) (0)
- AMYPAD-DPMS PRELIMINARY RESULTS: PARTICIPANTS’ BASELINE FEATURES (2019) (0)
- Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study (2019) (0)
- Biomarker profiles in a memory clinic population according to new Alzheimer diagnostic framework (2020) (0)
- New insight in the Alzheimer ' s disease progression revealed by a combination of functional and structural information (2010) (0)
- P2-172 The pattern of brain atrophy in mild cognitive impaired carriers of ApoE allele ϵ4: A voxel based morphometry study (2006) (0)
- Differential diagnosis of dementia combining web‐based cognitive testing and MRI (2020) (0)
- Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial (2020) (0)
- Experiences of Active Everyday Life Among Persons with Prodromal Alzheimer’s Disease: A Qualitative Study (2022) (0)
- Metabolomics analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2021) (0)
- COMBINING STRUCTURAL MR, COGNITIVE AND GENETIC MARKERS IN PREDICTING FUTURE DEMENTIA: SIX-YEAR FOLLOW-UP OF A POPULATION-BASED SAMPLE (2017) (0)
- Rates of cognitive decline during the preclinical phase and their use in predicting future dementia (2020) (0)
- WW‐FINGERS‐SARS‐CoV2 in Finland: Changes in lifestyle and risk factors for cognitive impairment during the pandemic in the FINGER study (2021) (0)
- ERRATUM. (2021) (0)
- 40 Prevention of Alzheimer's disease, is it possible? (2012) (0)
- The effects of diabetes mellitus on neuropathologic findings at autopsy: The Vantaa 85+ Study (2009) (0)
- European memory clinic clinicians’ preferences and needs for communication with patients (2023) (0)
- C‐reactive protein, APOE status, and cognitive impairment in older adults (2022) (0)
- Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer’s Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial (2023) (0)
- Impact of the COVID-19 pandemic on statistical design and analysis plans formultidomain intervention clinical trials: Experience fromWorld-Wide FINGERS (2021) (0)
- Key symposium: updating Alzheimer's disease diagnosis ‐ implications for prevention and treatment (2014) (0)
- P1-364: Plasma levels of 24S-hydroxycholesterol are related to brain volumes in memory clinic patients (2008) (0)
- ACUTE KIDNEY IN COVID-19 PATIENTS: A MULTICENTRE STUDY BY TURKISH SOCIETY OF NEPHROLOGY (2021) (0)
- Cognitive Performance at Time of AD Diagnosis: A Clinically Augmented Register-Based Study (2022) (0)
- O3-04-03 Physical activity at midlife and the risk of dementia and Alzheimer’s disease (2006) (0)
- Adherence to in‐person vs. virtual delivery of a multi‐domain behavioral intervention to prevent cognitive decline: The US POINTER Study (2022) (0)
- Multimodal preventive trial for Alzheimer’s disease (MIND‐ADMINI): Pilot trial progress and results (2021) (0)
- A stepwise approach towards diagnostic workup in dementia using online cognitive tools (2021) (0)
- MULTIDOMAIN INTERVENTION TO PREVENT COGNITIVE IMPAIRMENT AND DEMENTIA (2018) (0)
- Lifestyle and psychosocial changes in Mexican elders during the COVID‐19 pandemic (2022) (0)
- Alzheimer prevention: Walk the talk (2010) (0)
- Contents Vol. 28, 2007 (2007) (0)
- Memory clinic clinicians’ preferences and needs for communication with patients: A multi‐national survey study from EU‐FINGERS & LETHE projects (2022) (0)
- P3-125 Fat intake at midlife and cognitive impairment later in life: A population-based study (2006) (0)
- LONGITUDINAL COGNITIVE PERFORMANCE IN THE OLDEST OLD WITH NO DEMENTIA: A-BETA OR OTHER PATHOLOGIES? (0)
- P4-089: Vitamin E plasma level and risk of dementia: Results from the Kungsholmen Project (2008) (0)
- Antioxidants and Dementia (2022) (0)
- The association of the ANU‐ADRI Alzheimer risk index score with cognition in the FINGER study (2021) (0)
- The impact of a nutritional intervention in prodromal Alzheimer’s disease: The LipiDiDiet clinical trial (2020) (0)
- Why Alzheimer patients and caregivers participate in randomized clinical trials (2009) (0)
- Influence of lifespan cognitive reserve indicator on cognitive trajectories in different domains: role of brain pathologies (2021) (0)
- Reply (2005) (0)
- [Genetics of Alzheimer's disease]. (2012) (0)
- Faculty Opinions recommendation of Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. (2015) (0)
- Serum proBDNF availability predicts memory gains in the FINGER multimodal lifestyle intervention (2021) (0)
- IMPACT OF BASELINE BRAIN MRI MEASURES ON COGNITIVE EFFECTS OF A MULTIDOMAIN INTERVENTION: THE FINGER RANDOMIZED CONTROLLED TRIAL (2017) (0)
- MULTIDOMAIN LIFESTYLE INTERVENTION, TELOMERE LENGTH CHANGE AND COGNITION: THE FINGER TRIAL (2017) (0)
- Post-menopausal hormone therapy and Alzheimer's disease: A prospective cohort study (2015) (0)
- Occupational complexity and neuroimaging measures of structural MRI and PET‐amyloid in a randomized controlled trial: FINGER (2021) (0)
- Cardiorespiratory Fitness And Brain Structures - The Finger Study: 1007 Board #4 May 27, 3 (2015) (0)
- Effect of occupational complexity on cognitive change during a multidomain lifestyle intervention: The FINGER trial (2020) (0)
- Impact of baseline impaired sleep, depressive symptoms and pain on physical activity in the FINGER multidomain lifestyle trial (2020) (0)
- Physical activity and sedentary time in a multimodal lifestyle intervention in prodromal Alzheimer’s disease: The MIND‐ADMINI pilot trial (2021) (0)
- Faculty Opinions recommendation of Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer's disease: a 38-year longitudinal population study. (2015) (0)
- O1-01-03 Healthy lifestyle reduces the risk of dementia especially among the apolipoprotein E e4 carriers (2007) (0)
- Changes in modifiable risk factors for Alzheimer´s disease and dementia during the COVID‐19 pandemic in Swedish older adults: a population‐based digital survey (2022) (0)
- Social functioning and cognitive impairment among the oldest old (2021) (0)
- Associations of Depressive Symptoms and Cognition in the FINGER Trial: A Secondary Analysis of a Randomised Clinical Trial (2022) (0)
- Methodological challenges across WW‐FINGERS Studies: Impact of COVID‐19 pandemic on statistical design and analysis plans for multidomain RCTs (2021) (0)
- Prediction models for dementia and neuropathology in the oldest old Hall , Anette 2019-01-22 (0)
- O1-02-07 The CAIDE dementia risk score: A practical tool to predict dementia risk in 20 years among middle aged persons (2007) (0)
- WHITE MATTER CHANGES ON DIFFUSION TENSOR IMAGING IN THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2016) (0)
- Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbidities (2022) (0)
- CAIDE DEMENTIA RISK SCORE, ALZHEIMER, AND VASCULAR NEUROPATHOLOGY IN THE VANTAA 85+ STUDY (2014) (0)
- Tocopherols And Tocotrienols Plasma Levels And The Risk Of Alzheimer's Disease In The Oldest Old: Results From The Kungsholmen Project (2009) (0)
- Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 (2021) (0)
- Neuro‐COVID: Does severe COVID‐19 infection increase the risk for cognitive impairment? (2021) (0)
- Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 (2021) (0)
- Research diagnostic criteria for Alzheimer’s disease: Findings from the multinational LipiDiDiet Trial (2020) (0)
- IC-P-048 MRI in mild cognitive impairment and predictive value to dementia on a follow-up study (2006) (0)
- Tools for harmonization of data in World‐Wide FINGERS (2021) (0)
- Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models (2023) (0)
- Author response: Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies (2017) (0)
- P2-154 Is the CSF level of 24S-hydroxycholesterol a sensitive biomarker for early Alzheimer’s disease? (2006) (0)
- Association between sleep, depressive symptoms, and pain with physical activity and physical functioning in the oldest old: CAIDE 85+ study (2021) (0)
- European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. (2023) (0)
- A rare success against alzheimer’s. (cover story) (2017) (0)
- Midlife hopelessness and white matter lesions two decades later: A population-based study (2011) (0)
- The vitamin E family in Alzheimer's disease and mild cognitive impairment: Results from the AddNeuroMed study (2011) (0)
- Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)
- PARTICIPANTS’ EXPERIENCES OF MULTIDOMAIN LIFESTYLE-BASED INTERVENTION (FINGER) TO PREVENT COGNITIVE DECLINE (2017) (0)
- Current status and quantitative results of the AMYPAD prognostic and natural history study (2020) (0)
- INFLUENCE OF APOE, AGE, SEX, EDUCATION AND BASELINE COGNITION ON INTERVENTION EFFECTS ON COGNITION IN THE FINNISH GERIATRIC INTERVENTION STUDY TO PREVENT COGNITIVE IMPAIRMENT AND DISABILITY (FINGER) (2016) (0)
- S4-03-04: Prognostic models for cognitive impairment and midlife risk (2008) (0)
- MIDLIFE SELF-RATED HEALTH AND FITNESS IN RELATION TO WHITE MATTER LESIONS AND GREY MATTER VOLUME 20 YEARS LATER (2014) (0)
- Sex differences in dementia : Evidence from population-based studies and a lifestyle intervention (2019) (0)
- S1-01-06 Integrative view of metabolic syndrome features—from cardiovascular disease to dementia (2006) (0)
- Heterogeneity in normal aging: longitudinal trajectories of grey matter (2022) (0)
- Cholesterol, Statins, and Late-Life Cognitive Disorders (2013) (0)
- MULTIMODAL LIFESTYLE AND NUTRITIONAL INTERVENTION IN PRODROMAL ALZHEIMER’S DISEASE: MIND-ADMINI PILOT TRIAL (2017) (0)
- Twenty years change in cholesterol and risk of dementia (2009) (0)
- Rheumatoid arthritis at midlife and the risk of cognitive impairment two decades later: A population-based study (2011) (0)
- APOE genotype and multimorbidity in the FINGER multidomain lifestyle trial (2020) (0)
- Perceived marital problems in midlife are associated with cognitive health in later life (2011) (0)
- Markers of vitamin B12 status in relation to CSF biomarkers and cognitive performance (2022) (0)
- P1-218 The dementia risk score—a practical tool to predict dementia risk in 20 years among middle aged persons (2006) (0)
- Associations of Health, Lifestyle and Psycho-Social Factors With Sleep Quality During the Early Phase of the COVID-19 Pandemic: A Focus on UK Older Adults Deemed Clinically Extremely Vulnerable (2021) (0)
- P3-147 Alcohol drinking at midlife and the risk of mild cognitive impairment and dementia in late-life (2004) (0)
- Physical Activity Modifies Risk of Dementia and Alzheimer's Disease: 462 (2008) (0)
This paper list is powered by the following services:
Other Resources About Miia Kivipelto
What Schools Are Affiliated With Miia Kivipelto?
Miia Kivipelto is affiliated with the following schools:
